Sun Pharmaceutical Industries Limited

This study tests a new medicine called GL0034, given as a weekly shot, for people with type 2 diabetes who are also overweight or obese. About 285 adults will receive either the study drug or a placebo for up to 48 weeks. The main goal is to see if GL0034 can lower blood sugar le…

This study looks at how different levels of kidney function affect the way the body handles a new long-acting diabetes drug called GL0034. About 40 adults with type 2 diabetes will receive one dose of the drug. Researchers will measure drug levels in the blood and check for side …